Author:
Kiertiburanakul Sasisopin, ,Boettiger David,Ng Oon Tek,Van Kinh Nguyen,Merati Tuti Parwati,Avihingsanon Anchalee,Wong Wing-Wai,Lee Man Po,Chaiwarith Romanee,Kamarulzaman Adeeba,Kantipong Pacharee,Zhang Fujie,Choi Jun Yong,Kumarasamy Nagalingeswaran,Ditangco Rossana,Cuong Do Duy,Oka Shinichi,Sim Benedict Lim Heng,Ratanasuwan Winai,Ly Penh Sun,Yunihastuti Evy,Pujari Sanjay,Ross Jeremy L.,Law Matthew,Sungkanuparph Somnuek
Funder
International Epidemiologic Databases to Evaluate AIDS
the Australian Government Department of Health and Ageing
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Virology,Molecular Medicine
Reference17 articles.
1. Taddei TH, Lo Re V 3rd, Justice AC. HIV, aging, and viral coinfections: taking the long view. Curr HIV/AIDS Rep. 2016;13:269–78.
2. Kiertiburanakul S, Luengroongroj P, Sungkanuparph S. Clinical characteristics of HIV-infected patients who survive after the diagnosis of HIV infection for more than 10 years in a resource-limited setting. J Int Assoc Physicians AIDS Care (Chic). 2012;11:361–5.
3. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375:830–9.
4. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services.
http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
. Accessed 14 Sep 2016.
5. Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society—USA panel. JAMA. 2016;316:191–210.